In familial Mediterranean fever, soluble TREM-1 plasma level is higher in case of amyloidosis

In familial Mediterranean fever, soluble TREM-1 plasma level is higher in case of amyloidosis

We aimed to explore triggering receptor expressed on myeloid cells-1 (TREM-1) activation in familial Mediterranean fever (FMF), the most frequent monogenic auto-inflammatory disease, through the measurement of its serum soluble form, named sTREM-1. Blood samples from patients with FMF according to L...

Full description

Bibliographic Details
Main Authors:	Clémence Gorlier, Jérémie Sellam, Ludivine Laurans, Tabassome Simon, Irina Giurgea, Jean-Philippe Bastard, Soraya Fellahi, Samuel Deshayes, Gilles Grateau, Hafid Ait Oufella, Sophie Georgin-Lavialle
Format:	Article
Language:	English
Published:	SAGE Publishing 2019-11-01
Series:	Innate Immunity
Online Access:	https://doi.org/10.1177/1753425919870847

Similar Items

Response to Letter to the Editor
by: Clémence Gorlier, et al.
Published: (2020-04-01)

Role of non-invasive methods in detecting liver impairment in familial Mediterranean fever adult patients with persistent hepatic cytolysis
by: Samuel Deshayes, et al.
Published: (2022-10-01)

Soluble TREM-1 plasma levels are associated with acute kidney injury, acute atrial fibrillation and prolonged ICU stay after cardiac surgery- a proof-concept study
by: Marie Vandestienne, et al.
Published: (2023-07-01)

In Familial Mediterranean Fever, soluble TREM-1 plasma level is higher in case of amyloidosis
by: Serdal Ugurlu, et al.
Published: (2020-04-01)

Adaptive Immune Responses Contribute to Post-ischemic Cardiac Remodeling
by: Icia Santos-Zas, et al.
Published: (2019-01-01)

Amyloid and amyloidosis /
by: Skinner, Martha, et al.
Published: (2005)

TREM2 splice isoforms generate soluble TREM2 species that disrupt long-term potentiation
by: Miguel Moutinho, et al.
Published: (2023-02-01)

Trem2 H157Y increases soluble TREM2 production and reduces amyloid pathology
by: Wenhui Qiao, et al.
Published: (2023-01-01)

Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers
by: Nicholas J. Ashton, et al.
Published: (2019-11-01)

The role of adaptive T cell immunity in atherosclerosis
by: Ziad Mallat, et al.
Published: (2009-01-01)

Correction: Trem2 H157Y increases soluble TREM2 production and reduces amyloid pathology
by: Wenhui Qiao, et al.
Published: (2023-04-01)

Does Soluble TREM2 Protect Against Alzheimer's Disease?
by: Guy C. Brown, et al.
Published: (2022-01-01)

Increased CSF Soluble TREM2 Concentration in Patients With Neurosyphilis
by: Wurong Li, et al.
Published: (2020-02-01)

TREM2 ectodomain and its soluble form in Alzheimer’s disease
by: Jiaolong Yang, et al.
Published: (2020-07-01)

The Emerging Roles and Therapeutic Potential of Soluble TREM2 in Alzheimer’s Disease
by: Li Zhong, et al.
Published: (2019-11-01)

The relationship of soluble TREM2 to other biomarkers of sporadic Alzheimer’s disease
by: So-Hee Park, et al.
Published: (2021-06-01)

Impact of human monocyte and macrophage polarization on NLR expression and NLRP3 inflammasome activation.
by: Fawaz Awad, et al.
Published: (2017-01-01)

INPP5D modulates TREM2 loss-of-function phenotypes in a β-amyloidosis mouse model
by: Akihiro Iguchi, et al.
Published: (2023-04-01)

Angiotensin II synergizes with BAFF to promote atheroprotective regulatory B cells
by: Padmapriya Ponnuswamy, et al.
Published: (2017-06-01)

The Prognostic Value of Serum Soluble TREM-1 on Outcome in Adult Patients with Sepsis
by: Chia-Te Kung, et al.
Published: (2021-10-01)

Soluble TREM2 is a potential biomarker for the severity of primary angiitis of the CNS
by: Tianshu Guo, et al.
Published: (2022-12-01)

Circulating Soluble TREM2 and Cardiovascular Outcome in Cohort Study of Coronary Atherosclerosis Patients
by: Valeri Cuciuc, et al.
Published: (2022-10-01)

Soluble TREM-1 plasma concentration predicts poor outcome in COVID-19 patients
by: Sébastien Gibot, et al.
Published: (2023-08-01)

Genome-Wide Association Studies for Cerebrospinal Fluid Soluble TREM2 in Alzheimer’s Disease
by: Changan Liu, et al.
Published: (2019-10-01)

Regulatory T Cell-Enhancing Therapies to Treat Atherosclerosis
by: Hafid Ait-Oufella, et al.
Published: (2021-03-01)

Function of TREM1 and TREM2 in Liver-Related Diseases
by: Huifang Sun, et al.
Published: (2020-12-01)

Long-Term Follow-Up and Optimization of Interleukin-1 Inhibitors in the Management of Monogenic Autoinflammatory Diseases: Real-Life Data from the JIR Cohort
by: Véronique Hentgen, et al.
Published: (2021-01-01)

Response letter to “Latent class analysis of 216 patients with adult-onset Still’s disease” by Sugiyama et al.
by: Marion Delplanque, et al.
Published: (2022-12-01)

Commentary: ‘Case Report: A Rare Case of Elderly-Onset Adult Onset Still’s Disease in a Patient With Systemic Lupus Erythematous’
by: Marion Delplanque, et al.
Published: (2022-04-01)

Soluble TREM2 levels associate with conversion from mild cognitive impairment to Alzheimer’s disease
by: Aonan Zhao, et al.
Published: (2022-12-01)

The associations between plasma soluble Trem1 and neurological diseases: a Mendelian randomization study
by: Xiaolei Shi, et al.
Published: (2022-09-01)

Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup
by: Ione O. C. Woollacott, et al.
Published: (2018-08-01)

Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer’s disease model
by: Li Zhong, et al.
Published: (2019-03-01)

Trem de doido
by: Raquel Gonçalves de Sousa, et al.
Published: (2023-12-01)

TREM-1, TREM-2 and their association with disease severity in patients with COVID-19
by: Ruyue Fan, et al.
Published: (2023-12-01)

Vasculitis and familial Mediterranean fever: Description of 22 French adults from the juvenile inflammatory rheumatism cohort
by: Salam Abbara, et al.
Published: (2022-10-01)

Soluble triggering receptor expressed on myeloid cells 1 (sTREM-1) and polymorphic variants of TREM-1 in the development of multiple organ dysfunction syndrome after coronary artery bypass grafting
by: M. V. Khutornya, et al.
Published: (2019-07-01)

Recruiting the microcirculation in septic shock
by: Matthieu Legrand, et al.
Published: (2019-09-01)

Correction to: Recruiting the microcirculation in septic shock
by: Matthieu Legrand, et al.
Published: (2019-09-01)

Amyloid Goiter in Familial Mediterranean Fever: Description of 42 Cases from a French Cohort and from Literature Review
by: Hélène Vergneault, et al.
Published: (2021-05-01)